SCHEMBL13291229

SCHEMBL13291229

CC(C)(C)c1ccc2c(c1)c1cc(N(c3ccc(-c4ccc5ccccc5c4)cc3)c3ccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)cc3)ccc1n2-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 3/20 0.35
▸ SERPINE1 P05121 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PGR P06401 1/20 0.32
▸ RORA P35398 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ RORB Q92753 1/20 0.32
▸ PPARG P37231 2/20 0.31
▸ GPR84 Q9NQS5 1/20 0.31
▸ TSPO P30536 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291236 0.96 PTGES (0.37) PTGESSERPINE1ALDH1A1MAPTMAPK1
SCHEMBL13291155 0.94 PTGES (0.37) PTGESSERPINE1ALDH1A1MAPTMAPK1
SCHEMBL13291213 0.93 PTGES (0.38) PTGESSERPINE1ALDH1A1MAPTMAPK1
SCHEMBL14521317 0.91 KMT2A (0.37) PTGESSERPINE1ALDH1A1MAPTMAPK1
SCHEMBL10175788 0.90 KMT2A (0.34) PTGESSERPINE1ALDH1A1MAPTMAPK1
SCHEMBL14029453 0.90 KMT2A (0.36) PTGESSERPINE1ALDH1A1MAPTMAPK1
SCHEMBL13291146 0.90 L3MBTL1 (0.41) PTGESALDH1A1MAPTKMT2ATSPO
SCHEMBL13291140 0.90 L3MBTL1 (0.41) PTGESALDH1A1MAPTKMT2ATSPO
SCHEMBL13291143 0.90 L3MBTL1 (0.41) PTGESALDH1A1MAPTKMT2ATSPO
SCHEMBL13291142 0.90 L3MBTL1 (0.41) PTGESALDH1A1MAPTKMT2ATSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 — — US disclosed
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE GLB1, CYP1A1, CRY1 PTGES 154/4885SERPINE1 2413/4885ALDH1A1 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback